Structure

Physi-Chem Properties

Molecular Weight:  556.23
Volume:  545.544
LogP:  2.546
LogD:  1.534
LogS:  -4.668
# Rotatable Bonds:  7
TPSA:  138.57
# H-Bond Aceptor:  10
# H-Bond Donor:  1
# Rings:  6
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.425
Synthetic Accessibility Score:  6.199
Fsp3:  0.667
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.304
MDCK Permeability:  2.9330243705771863e-05
Pgp-inhibitor:  0.997
Pgp-substrate:  0.144
Human Intestinal Absorption (HIA):  0.352
20% Bioavailability (F20%):  0.99
30% Bioavailability (F30%):  0.984

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.529
Plasma Protein Binding (PPB):  77.97940826416016%
Volume Distribution (VD):  1.053
Pgp-substrate:  17.600221633911133%

ADMET: Metabolism

CYP1A2-inhibitor:  0.01
CYP1A2-substrate:  0.288
CYP2C19-inhibitor:  0.15
CYP2C19-substrate:  0.233
CYP2C9-inhibitor:  0.102
CYP2C9-substrate:  0.014
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.054
CYP3A4-inhibitor:  0.924
CYP3A4-substrate:  0.607

ADMET: Excretion

Clearance (CL):  2.493
Half-life (T1/2):  0.642

ADMET: Toxicity

hERG Blockers:  0.038
Human Hepatotoxicity (H-HT):  0.474
Drug-inuced Liver Injury (DILI):  0.477
AMES Toxicity:  0.526
Rat Oral Acute Toxicity:  0.99
Maximum Recommended Daily Dose:  0.407
Skin Sensitization:  0.451
Carcinogencity:  0.906
Eye Corrosion:  0.005
Eye Irritation:  0.016
Respiratory Toxicity:  0.985

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC236004

Natural Product ID:  NPC236004
Common Name*:   Moluccensin I
IUPAC Name:   n.a.
Synonyms:   Moluccensin I
Standard InCHIKey:  DXAWUJPEJQPCGT-IQXSIFHKSA-N
Standard InCHI:  InChI=1S/C30H36O10/c1-15(31)39-25-27(3)14-29(35)28(4,19(27)12-20(32)36-5)17-7-9-26(2)18(22(17)23(34)30(25,29)37-6)11-21(33)40-24(26)16-8-10-38-13-16/h8,10,13,17,19,24-25,35H,7,9,11-12,14H2,1-6H3/t17-,19-,24-,25-,26+,27-,28+,29+,30+/m0/s1
SMILES:  COC(=O)C[C@H]1[C@]2(C)C[C@]3([C@]1(C)[C@H]1CC[C@@]4(C(=C1C(=O)[C@]3([C@H]2OC(=O)C)OC)CC(=O)O[C@H]4c1ccoc1)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1076925
PubChem CID:   46184328
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids
          • [CHEMONTID:0002380] Limonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[20112995]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[20146503]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds Thai n.a. PMID[21733687]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[22724531]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[26114936]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT845 Cell Line BT-474 Homo sapiens IC50 > 10.0 ug.mL-1 PMID[482295]
NPT65 Cell Line HepG2 Homo sapiens IC50 > 10.0 ug.mL-1 PMID[482295]
NPT323 Cell Line SW-620 Homo sapiens IC50 > 10.0 ug.mL-1 PMID[482295]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 10.0 ug.mL-1 PMID[482295]
NPT4025 Organism Staphylococcus hominis Staphylococcus hominis MIC = 256.0 ug.mL-1 PMID[482295]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC = 223.0 ug.mL-1 PMID[482295]
NPT4696 Organism Brontispa longissima Brontispa longissima Activity = 10.7 % PMID[482296]
NPT4696 Organism Brontispa longissima Brontispa longissima Activity = 28.7 % PMID[482296]
NPT2 Others Unspecified IC50 > 27000.0 nM PMID[482297]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC236004 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9876 High Similarity NPC94763
0.9755 High Similarity NPC478177
0.9632 High Similarity NPC469576
0.9627 High Similarity NPC327922
0.9573 High Similarity NPC469633
0.9503 High Similarity NPC478178
0.95 High Similarity NPC165218
0.9286 High Similarity NPC470938
0.9277 High Similarity NPC471437
0.9273 High Similarity NPC159232
0.9207 High Similarity NPC478179
0.9152 High Similarity NPC472766
0.9152 High Similarity NPC472765
0.9091 High Similarity NPC476224
0.9091 High Similarity NPC472764
0.9042 High Similarity NPC285227
0.903 High Similarity NPC149945
0.9024 High Similarity NPC469338
0.9024 High Similarity NPC292389
0.9012 High Similarity NPC36655
0.9012 High Similarity NPC261597
0.9012 High Similarity NPC247563
0.9012 High Similarity NPC242068
0.9006 High Similarity NPC214541
0.9006 High Similarity NPC44675
0.8982 High Similarity NPC472659
0.8976 High Similarity NPC173516
0.897 High Similarity NPC469849
0.897 High Similarity NPC276551
0.897 High Similarity NPC470940
0.8963 High Similarity NPC82851
0.8963 High Similarity NPC6326
0.8957 High Similarity NPC477403
0.8957 High Similarity NPC475967
0.8941 High Similarity NPC470181
0.8922 High Similarity NPC471397
0.8922 High Similarity NPC271235
0.8916 High Similarity NPC214600
0.8916 High Similarity NPC470875
0.8902 High Similarity NPC472653
0.8902 High Similarity NPC105395
0.8902 High Similarity NPC477402
0.8896 High Similarity NPC187149
0.8889 High Similarity NPC264943
0.8876 High Similarity NPC469848
0.8869 High Similarity NPC470995
0.8862 High Similarity NPC472775
0.8862 High Similarity NPC472774
0.8862 High Similarity NPC472651
0.8848 High Similarity NPC5079
0.8848 High Similarity NPC149896
0.8848 High Similarity NPC472767
0.8848 High Similarity NPC69028
0.8824 High Similarity NPC471632
0.8817 High Similarity NPC169299
0.8817 High Similarity NPC160818
0.881 High Similarity NPC472652
0.881 High Similarity NPC160651
0.8795 High Similarity NPC39986
0.8795 High Similarity NPC663
0.8795 High Similarity NPC224394
0.8795 High Similarity NPC134254
0.8795 High Similarity NPC302369
0.8795 High Similarity NPC472773
0.8795 High Similarity NPC51568
0.8795 High Similarity NPC477405
0.8795 High Similarity NPC234660
0.8788 High Similarity NPC25255
0.878 High Similarity NPC195131
0.878 High Similarity NPC45101
0.878 High Similarity NPC249021
0.878 High Similarity NPC286722
0.878 High Similarity NPC299038
0.878 High Similarity NPC472777
0.878 High Similarity NPC472776
0.878 High Similarity NPC472778
0.878 High Similarity NPC470118
0.875 High Similarity NPC476850
0.875 High Similarity NPC476861
0.8743 High Similarity NPC476857
0.8743 High Similarity NPC470182
0.8743 High Similarity NPC271657
0.8743 High Similarity NPC476856
0.8743 High Similarity NPC476858
0.8743 High Similarity NPC123088
0.8735 High Similarity NPC472668
0.8735 High Similarity NPC329938
0.8735 High Similarity NPC197596
0.8735 High Similarity NPC18347
0.8735 High Similarity NPC200782
0.8735 High Similarity NPC193798
0.8735 High Similarity NPC472771
0.8727 High Similarity NPC475295
0.8727 High Similarity NPC473473
0.8727 High Similarity NPC475226
0.872 High Similarity NPC469485
0.872 High Similarity NPC204663
0.872 High Similarity NPC209364
0.8713 High Similarity NPC477824
0.869 High Similarity NPC472141
0.8683 High Similarity NPC472139
0.8683 High Similarity NPC469846
0.8683 High Similarity NPC472669
0.8683 High Similarity NPC471168
0.8675 High Similarity NPC335761
0.8675 High Similarity NPC470789
0.8667 High Similarity NPC472283
0.8667 High Similarity NPC173544
0.8667 High Similarity NPC197137
0.8659 High Similarity NPC155939
0.8659 High Similarity NPC296807
0.8659 High Similarity NPC141538
0.865 High Similarity NPC476201
0.865 High Similarity NPC469503
0.8647 High Similarity NPC82602
0.8647 High Similarity NPC472650
0.8639 High Similarity NPC476853
0.8639 High Similarity NPC472282
0.8631 High Similarity NPC476860
0.8623 High Similarity NPC263432
0.8623 High Similarity NPC188649
0.8623 High Similarity NPC470939
0.8623 High Similarity NPC471167
0.8623 High Similarity NPC5741
0.8623 High Similarity NPC470792
0.8623 High Similarity NPC117986
0.8623 High Similarity NPC96443
0.8623 High Similarity NPC290400
0.8623 High Similarity NPC471166
0.8614 High Similarity NPC474932
0.8606 High Similarity NPC107646
0.8606 High Similarity NPC126723
0.8598 High Similarity NPC282445
0.858 High Similarity NPC23387
0.8571 High Similarity NPC88841
0.8571 High Similarity NPC288602
0.8563 High Similarity NPC475381
0.8563 High Similarity NPC191828
0.8555 High Similarity NPC262386
0.8554 High Similarity NPC167142
0.8554 High Similarity NPC472772
0.8545 High Similarity NPC469336
0.8545 High Similarity NPC92979
0.8545 High Similarity NPC476262
0.8537 High Similarity NPC33938
0.8537 High Similarity NPC44577
0.8528 High Similarity NPC470997
0.8521 High Similarity NPC259943
0.8512 High Similarity NPC211777
0.8503 High Similarity NPC472671
0.8503 High Similarity NPC237155
0.8503 High Similarity NPC307383
0.8503 High Similarity NPC472779
0.8494 Intermediate Similarity NPC60973
0.8485 Intermediate Similarity NPC178932
0.8485 Intermediate Similarity NPC34421
0.8485 Intermediate Similarity NPC98206
0.8485 Intermediate Similarity NPC253201
0.8485 Intermediate Similarity NPC302054
0.8485 Intermediate Similarity NPC57998
0.8485 Intermediate Similarity NPC237259
0.848 Intermediate Similarity NPC472673
0.848 Intermediate Similarity NPC242334
0.8476 Intermediate Similarity NPC18135
0.8476 Intermediate Similarity NPC116717
0.8471 Intermediate Similarity NPC97574
0.8471 Intermediate Similarity NPC475779
0.8471 Intermediate Similarity NPC93172
0.8466 Intermediate Similarity NPC234494
0.8466 Intermediate Similarity NPC472654
0.8466 Intermediate Similarity NPC69647
0.8466 Intermediate Similarity NPC471001
0.8466 Intermediate Similarity NPC125182
0.8462 Intermediate Similarity NPC198047
0.8457 Intermediate Similarity NPC255414
0.8452 Intermediate Similarity NPC305016
0.8443 Intermediate Similarity NPC88007
0.8443 Intermediate Similarity NPC214495
0.8443 Intermediate Similarity NPC475066
0.8443 Intermediate Similarity NPC470119
0.8434 Intermediate Similarity NPC471175
0.8434 Intermediate Similarity NPC281258
0.8424 Intermediate Similarity NPC470996
0.8424 Intermediate Similarity NPC268905
0.8424 Intermediate Similarity NPC246164
0.8424 Intermediate Similarity NPC472672
0.8421 Intermediate Similarity NPC473766
0.8421 Intermediate Similarity NPC473753
0.8421 Intermediate Similarity NPC100333
0.8415 Intermediate Similarity NPC159927
0.8415 Intermediate Similarity NPC156189
0.8415 Intermediate Similarity NPC196846
0.8415 Intermediate Similarity NPC469335
0.8415 Intermediate Similarity NPC476122
0.8412 Intermediate Similarity NPC261184
0.8402 Intermediate Similarity NPC68848
0.8402 Intermediate Similarity NPC207978
0.8395 Intermediate Similarity NPC346
0.8393 Intermediate Similarity NPC262872
0.8383 Intermediate Similarity NPC175964

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC236004 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8659 High Similarity NPD5761 Phase 2
0.8659 High Similarity NPD5760 Phase 2
0.8212 Intermediate Similarity NPD8434 Phase 2
0.8129 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.8034 Intermediate Similarity NPD6764 Approved
0.8034 Intermediate Similarity NPD6765 Approved
0.7857 Intermediate Similarity NPD6785 Approved
0.7857 Intermediate Similarity NPD6784 Approved
0.7486 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD7075 Discontinued
0.7418 Intermediate Similarity NPD7799 Discontinued
0.738 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD6599 Discontinued
0.7209 Intermediate Similarity NPD7236 Approved
0.7191 Intermediate Similarity NPD7819 Suspended
0.7171 Intermediate Similarity NPD8404 Phase 2
0.7166 Intermediate Similarity NPD6559 Discontinued
0.7151 Intermediate Similarity NPD3817 Phase 2
0.7135 Intermediate Similarity NPD6801 Discontinued
0.7127 Intermediate Similarity NPD919 Approved
0.7102 Intermediate Similarity NPD7239 Suspended
0.7098 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7085 Intermediate Similarity NPD7497 Discontinued
0.7074 Intermediate Similarity NPD7685 Pre-registration
0.7069 Intermediate Similarity NPD6799 Approved
0.7065 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7017 Intermediate Similarity NPD3882 Suspended
0.6995 Remote Similarity NPD5494 Approved
0.6994 Remote Similarity NPD4628 Phase 3
0.6961 Remote Similarity NPD5402 Approved
0.6957 Remote Similarity NPD8127 Discontinued
0.6957 Remote Similarity NPD1247 Approved
0.6949 Remote Similarity NPD920 Approved
0.6923 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6919 Remote Similarity NPD5762 Approved
0.6919 Remote Similarity NPD5763 Approved
0.6915 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6906 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6898 Remote Similarity NPD7473 Discontinued
0.6897 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6893 Remote Similarity NPD6273 Approved
0.6891 Remote Similarity NPD8150 Discontinued
0.6885 Remote Similarity NPD3749 Approved
0.6875 Remote Similarity NPD8407 Phase 2
0.6865 Remote Similarity NPD7199 Phase 2
0.6862 Remote Similarity NPD3818 Discontinued
0.6862 Remote Similarity NPD3751 Discontinued
0.6859 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6854 Remote Similarity NPD5403 Approved
0.6851 Remote Similarity NPD1934 Approved
0.6845 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6845 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6845 Remote Similarity NPD6166 Phase 2
0.6836 Remote Similarity NPD642 Clinical (unspecified phase)
0.6836 Remote Similarity NPD5401 Approved
0.6833 Remote Similarity NPD4380 Phase 2
0.6825 Remote Similarity NPD5844 Phase 1
0.6806 Remote Similarity NPD7251 Discontinued
0.6806 Remote Similarity NPD8368 Discontinued
0.6796 Remote Similarity NPD7411 Suspended
0.6793 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6792 Remote Similarity NPD7907 Approved
0.6776 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6771 Remote Similarity NPD7808 Phase 3
0.6754 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6754 Remote Similarity NPD6797 Phase 2
0.6749 Remote Similarity NPD7435 Discontinued
0.6742 Remote Similarity NPD2532 Approved
0.6742 Remote Similarity NPD2534 Approved
0.6742 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6742 Remote Similarity NPD2533 Approved
0.6742 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6739 Remote Similarity NPD7057 Phase 3
0.6739 Remote Similarity NPD7058 Phase 2
0.6738 Remote Similarity NPD6232 Discontinued
0.6738 Remote Similarity NPD3787 Discontinued
0.6736 Remote Similarity NPD8313 Approved
0.6736 Remote Similarity NPD8312 Approved
0.6725 Remote Similarity NPD6355 Discontinued
0.6724 Remote Similarity NPD6005 Phase 3
0.6724 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6724 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6724 Remote Similarity NPD6002 Phase 3
0.6724 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6724 Remote Similarity NPD1471 Phase 3
0.6724 Remote Similarity NPD6004 Phase 3
0.6723 Remote Similarity NPD643 Clinical (unspecified phase)
0.6702 Remote Similarity NPD7074 Phase 3
0.6702 Remote Similarity NPD3926 Phase 2
0.6685 Remote Similarity NPD3226 Approved
0.6667 Remote Similarity NPD6234 Discontinued
0.6651 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6649 Remote Similarity NPD4965 Approved
0.6649 Remote Similarity NPD7054 Approved
0.6649 Remote Similarity NPD4966 Approved
0.6649 Remote Similarity NPD4967 Phase 2
0.6648 Remote Similarity NPD2800 Approved
0.6648 Remote Similarity NPD7028 Phase 2
0.663 Remote Similarity NPD2801 Approved
0.6629 Remote Similarity NPD2346 Discontinued
0.662 Remote Similarity NPD4111 Phase 1
0.662 Remote Similarity NPD4665 Approved
0.6615 Remote Similarity NPD7472 Approved
0.6601 Remote Similarity NPD4107 Approved
0.6597 Remote Similarity NPD7228 Approved
0.6596 Remote Similarity NPD6959 Discontinued
0.6591 Remote Similarity NPD1549 Phase 2
0.6579 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6576 Remote Similarity NPD37 Approved
0.6571 Remote Similarity NPD6099 Approved
0.6571 Remote Similarity NPD6100 Approved
0.6571 Remote Similarity NPD2796 Approved
0.6566 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6566 Remote Similarity NPD8435 Approved
0.6555 Remote Similarity NPD7874 Approved
0.6555 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6554 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6554 Remote Similarity NPD1243 Approved
0.6541 Remote Similarity NPD1465 Phase 2
0.6537 Remote Similarity NPD3057 Approved
0.6534 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6534 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6532 Remote Similarity NPD5735 Approved
0.6527 Remote Similarity NPD7078 Approved
0.652 Remote Similarity NPD6781 Approved
0.652 Remote Similarity NPD6782 Approved
0.652 Remote Similarity NPD6780 Approved
0.652 Remote Similarity NPD6778 Approved
0.652 Remote Similarity NPD6776 Approved
0.652 Remote Similarity NPD6779 Approved
0.652 Remote Similarity NPD6777 Approved
0.6519 Remote Similarity NPD1512 Approved
0.6517 Remote Similarity NPD3750 Approved
0.6514 Remote Similarity NPD2799 Discontinued
0.6509 Remote Similarity NPD5647 Approved
0.6503 Remote Similarity NPD7458 Discontinued
0.6497 Remote Similarity NPD970 Clinical (unspecified phase)
0.6494 Remote Similarity NPD6653 Approved
0.6492 Remote Similarity NPD2403 Approved
0.6488 Remote Similarity NPD4482 Phase 3
0.6484 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6482 Remote Similarity NPD8360 Approved
0.6482 Remote Similarity NPD8361 Approved
0.648 Remote Similarity NPD6190 Approved
0.6477 Remote Similarity NPD1551 Phase 2
0.6474 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6473 Remote Similarity NPD8320 Phase 1
0.6473 Remote Similarity NPD8319 Approved
0.6471 Remote Similarity NPD7768 Phase 2
0.6464 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6463 Remote Similarity NPD6319 Approved
0.6462 Remote Similarity NPD7240 Approved
0.6456 Remote Similarity NPD2972 Approved
0.6456 Remote Similarity NPD3533 Approved
0.6425 Remote Similarity NPD7697 Approved
0.6425 Remote Similarity NPD7696 Phase 3
0.6425 Remote Similarity NPD7698 Approved
0.6425 Remote Similarity NPD7893 Clinical (unspecified phase)
0.642 Remote Similarity NPD7033 Discontinued
0.642 Remote Similarity NPD3748 Approved
0.6413 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6412 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6409 Remote Similarity NPD1511 Approved
0.6407 Remote Similarity NPD7492 Approved
0.64 Remote Similarity NPD7048 Phase 3
0.6395 Remote Similarity NPD7095 Approved
0.6394 Remote Similarity NPD7870 Phase 2
0.6394 Remote Similarity NPD7871 Phase 2
0.6392 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6387 Remote Similarity NPD7315 Approved
0.6387 Remote Similarity NPD7229 Phase 3
0.6387 Remote Similarity NPD5711 Approved
0.6387 Remote Similarity NPD5710 Approved
0.6382 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6381 Remote Similarity NPD7701 Phase 2
0.6379 Remote Similarity NPD4140 Approved
0.6373 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6373 Remote Similarity NPD8485 Approved
0.6369 Remote Similarity NPD6616 Approved
0.6368 Remote Similarity NPD7801 Approved
0.6364 Remote Similarity NPD6054 Approved
0.6358 Remote Similarity NPD2313 Discontinued
0.6358 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6358 Remote Similarity NPD6798 Discontinued
0.6353 Remote Similarity NPD7319 Approved
0.6353 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6348 Remote Similarity NPD2344 Approved
0.6343 Remote Similarity NPD447 Suspended
0.6338 Remote Similarity NPD8462 Phase 1
0.6337 Remote Similarity NPD6832 Phase 2
0.6333 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6333 Remote Similarity NPD4110 Phase 3
0.6328 Remote Similarity NPD1510 Phase 2
0.6322 Remote Similarity NPD6233 Phase 2
0.6322 Remote Similarity NPD6663 Approved
0.6322 Remote Similarity NPD8032 Phase 2
0.6319 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6307 Remote Similarity NPD6353 Approved
0.6307 Remote Similarity NPD6651 Approved
0.6298 Remote Similarity NPD3887 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data